Patients (n) | ||
---|---|---|
Median age (years, range) | 56 (25-89) | |
Primary site | Cervix | 24 (54.6%) |
Vagina | 12 (27.3%) | |
Corpus | 5 (11.3%) | |
Ovary | 2 (4.5%) | |
Vulva | 1 (2.3%) | |
Primary therapy | 14 (31.8%) | |
Cervical cancer | 4 (9.1%) | |
Vaginal cancer | 10 (22.7%) | |
Salvage therapy | 30 (68.2%) | |
Post ope regidual tumor | 5 (11.4%) | |
Post ope recurrent tumor | 21 (47.7%) | |
Post RT recurrent tumor | 4 (9.1%) | |
Histology | Scc | 25 (56.8%) |
Adeno | 16 (36.4%) | |
Others | 3 (6.8%) | |
Prior pelvic RT* | Yes | 8 (18.2%) |
No | 36 (81.8%) | |
Median tumor size (cm, range) | 3.6 (1.0-8.0) | |
Pelvic LN† metastais | Yes | 11 (25%) |
No | 33 (75%) |